PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target ; volume:20 ; number:1 ; day:18 ; month:4 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of neuroinflammation ; 20, Heft 1 (18.4.2023), 1-19, 12.2023
- Urheber
-
Lind-Holm Mogensen, Frida
Scafidi, Andrea
Poli, Aurélie
Michelucci, Alessandro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-023-02776-z
- URN
-
urn:nbn:de:101:1-2023082921151245366865
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lind-Holm Mogensen, Frida
- Scafidi, Andrea
- Poli, Aurélie
- Michelucci, Alessandro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic drug monitoring in Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Function of Dj-1 in the pathoetiology of Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
Function of Dj-1 in the pathoetiology of Parkinson’s disease
Therapeutic drug monitoring in Parkinson’s disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Autoimmunity, dendritic cells and relevance for Parkinson’s disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Genotype-driven therapeutic developments in Parkinson’s disease
Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Zona incerta as a therapeutic target in Parkinson’s disease
Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches